Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention. [PDF]
Kumar NB +5 more
europepmc +1 more source
Trial-reported arthralgia of androgen deprivation therapy plus androgen receptor signaling inhibitors in prostate cancer: evidence from phase III randomized trials. [PDF]
Han Z +8 more
europepmc +1 more source
Androgen deprivation therapy and cognitive trajectories in Indian men: A 36-month prospective matched cohort analysis with Addenbrooke's cognitive examination-III. [PDF]
Gaurav G +5 more
europepmc +1 more source
Research Status of Androgen Deprivation Therapy Monotherapy and Combination Therapy for Prostate Cancer: A Scoping Review. [PDF]
Lu X, Bian X, Wang S, Ye D.
europepmc +1 more source
[A multi-level study of androgen deprivation therapy on the immune microenvironment in prostate cancer]. [PDF]
Tan Z, DU Y, Qin C, Xu T.
europepmc +1 more source
A Shot in the Dark: Unprecedented Complete Radiologic Response of Metastatic Prostate Cancer to Single-Dose Androgen Deprivation Therapy (ADT). [PDF]
Deshpande RS, Ahluwalia P.
europepmc +1 more source
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial. [PDF]
Trinh QD +11 more
europepmc +1 more source
Cost-effectiveness of an artificial intelligence predictive model for guiding androgen deprivation therapy in intermediate-risk prostate cancer. [PDF]
Courtney PT +8 more
europepmc +1 more source
Testosterone dynamics and oncologic safety in biochemically recurrent prostate cancer: An analysis of intermittent androgen deprivation therapy schedules. [PDF]
Lee JH +4 more
europepmc +1 more source

